US Patent Issued to DAIICHI SANKYO on July 14 for "Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide derivative" (Japanese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,512, issued on July 14, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Anti-EGFR antibody-drug conjugate with a cyclic dinucleotide derivative" was invented by Masayuki Ishizaki (Tokyo), Osamu Suzuki (Tokyo), Mariko Kyutoku (Tokyo), Hiroshi Yukiura (Tokyo), Kyoko Hara (Tokyo), Masataka Chihara (Tokyo), Takafumi Otsuka (Tokyo) and Teiji Wada (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "[Problem] It is desired to develop an antibody-drug conjugate capable of being systemically administered and delivering a STING agonist specifically to a target cells or organ (for example, a tumor lesion), and a therapeutic agent and/or therapeutic met...